CST3 and diabetic kidney disease: These findings suggest that assessing eGFR using both creatinine- and cystatin C-based equations to determine the ratio of the two is likely to add value to the clinical assessment of all individuals with type 2 diabetes and assist with identification of people who may benefit from intensification of measures that prevent the development of CVD and DKD, and perhaps other complications associated with mortality.